2017
DOI: 10.3892/mco.2017.1253
|View full text |Cite
|
Sign up to set email alerts
|

Isolated brain metastases prior to locoregional recurrence in hilar cholangiocarcinoma

Abstract: Abstract. Isolated brain metastases prior to locoregional recurrence from hilar cholangiocarcinoma (HCCA) following curative resection are an extremely rare event. Very few reports regarding brain metastasis prior to locoregional recurrence following curative resection have been published due to the fact that to differentiate brain metastases from HCCA recurrence is challenging, particular in the early stages, since the neurological findings of brain metastasis are occult and subtle. Any patient with HCCA who … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
3
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 8 publications
0
3
0
Order By: Relevance
“…Indeed, IDH mutations affect a few neoplasms, mainly myeloid hemopathies, which do not form brain tumors, and 2 rare solid tumors, chondrosarcomas and cholangiocarcinomas, for which brain metastases are extremely rare and which are characterized by a very different radiological presentation from diffuse gliomas. 25,26 The spectral analysis of all edited MRS data acquired in gliomas of subjects who were negative for the IDH1 or IDH2 mutations, as well as in healthy tissue, provided concentrations of 2HG <0.2 mM with CRLB = 999%, while for the subjects with IDH mutations 2HG was >0.6 mM and CRLB <50% for all but one subject (S07, CRLB = 273%). With the exception of S07, a net separation between 2 subgroups of subjects (those with detectable 2HG with CRLB <999% and those with nondetectable 2HG and CRLB = 999%) was established.…”
Section: Neuro-oncologymentioning
confidence: 99%
“…Indeed, IDH mutations affect a few neoplasms, mainly myeloid hemopathies, which do not form brain tumors, and 2 rare solid tumors, chondrosarcomas and cholangiocarcinomas, for which brain metastases are extremely rare and which are characterized by a very different radiological presentation from diffuse gliomas. 25,26 The spectral analysis of all edited MRS data acquired in gliomas of subjects who were negative for the IDH1 or IDH2 mutations, as well as in healthy tissue, provided concentrations of 2HG <0.2 mM with CRLB = 999%, while for the subjects with IDH mutations 2HG was >0.6 mM and CRLB <50% for all but one subject (S07, CRLB = 273%). With the exception of S07, a net separation between 2 subgroups of subjects (those with detectable 2HG with CRLB <999% and those with nondetectable 2HG and CRLB = 999%) was established.…”
Section: Neuro-oncologymentioning
confidence: 99%
“…The median duration between the diagnosis of cancer and the identification of brain metastases was 13.6 months (ranging from 7.3 to 52.8). [4] Here, we present an unusual case of a 79-year-old male with a remarkable history of distal CCA who presented with neurological symptoms indicative of brain metastasis. The rarity of such occurrences emphasizes the complexity of CCA metastatic behavior and the need for careful monitoring in long-term survivors.…”
Section: Introductionmentioning
confidence: 95%
“…The median duration between the diagnosis of cancer and the identification of brain metastases was 13.6 months (ranging from 7.3 to 52.8). [ 4 ]…”
Section: Introductionmentioning
confidence: 99%
“…The precise incidence of brain metastases (BMs) originating from BTC remains largely uncertain. Limited information is available, with only a handful of individual case reports and two sets of cases that have detailed these BMs from BTC [ [5] , [6] , [7] , [8] , [9] , [10] ]. According to the most recent case series, the occurrence rate of BTC-related BMs stands at 1.4 % [ 6 ].…”
Section: Introductionmentioning
confidence: 99%